Your PGx results, ready for the prescriber.
Arkstone PGx turns your lab's pharmacogenomic test results into a provider report with gene results and CPIC-guideline drug recommendations, plus a simple patient report with a shareable code.
CPIC guidelines only. No proprietary recommendations added.
PGx is in private beta: available to selected partner labs while we develop it. Features and availability may change.
Gene results
Drug recommendations
Plain-language results the patient can keep and share with any provider.
From genotype to guidance in three steps
Your lab keeps running the test. Arkstone handles the interpretation and the reporting.
Your lab runs the panel
Perform pharmacogenomic testing as you do today, then send the genotype results to Arkstone.
Results are interpreted
Each genotype is assigned a phenotype, and drug recommendations are applied directly from CPIC guidelines.
Two reports are delivered
One for the ordering provider, one for the patient, both generated from the same result.
Offer PGx interpretation without building it in-house
Guideline-based, nothing added
Every drug recommendation follows CPIC (Clinical Pharmacogenetics Implementation Consortium) guidelines. Nothing proprietary is layered on top.
Reports for provider and patient
Providers get gene results with drug recommendations. Patients get a simple report and a code they can share with their other providers.
Focus on the testing
Keep your lab's work on the bench. Arkstone maps genotypes to phenotypes and produces the reports.
Add PGx reporting to your lab
Talk to an Arkstone Partner Manager about adding PGx reporting to your lab.
Talk to a Partner Manager
Pick a time that suits you. We will talk through your panel, volume and LIS, and how PGx reports reach the clinicians you serve.
Please do not include patient information.